Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oxysterol-binding protein (OSBP) is the founding member of a conserved family of lipid transfer proteins (ORPs/OSBPLs) that facilitate the non-vesicular transport of lipids between organelles at membrane contact sites (UniProt: P22059). OSBP primarily functions at the endoplasmic reticulum (ER)-Golgi interface, where it mediates the counter-directional exchange of cholesterol and phosphatidylinositol 4-phosphate (PI4P) (PubMed: 24855905). This activity is crucial for maintaining the lipid composition of the Golgi apparatus and supporting various cellular processes, including vesicular trafficking and signaling (PubMed: 33556339). In the context of disease, OSBP is a critical host factor for the replication of numerous plus-strand RNA viruses, such as enteroviruses and coronaviruses, which hijack OSBP to form viral replication organelles (PubMed: 25512477). Additionally, OSBP and its relative ORP4 are implicated in cancer cell proliferation and survival, making them attractive targets for antiviral and antineoplastic therapies (PubMed: 21854931). Several small molecules, collectively termed ORPphilins (e.g., OSW-1, schweinfurthins) and repurposed drugs like itraconazole, exert their effects by binding to the OSBP-related ligand-binding domain (ORD), thereby inhibiting lipid transfer or inducing protein degradation (PubMed: 26859458). These interactions disrupt the formation of viral replication complexes and impair the growth of various cancer cell lines.
Inhibition of non-vesicular lipid transfer (cholesterol/PI4P exchange) at membrane contact sites, disruption of viral replication organelles, and induction of target protein degradation.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oxysterol-binding protein (OSBP) (OSBP).